{"References": [{"title": "Engineered antibodies for improved passive immunization", "authors": "Chames P, Baty D, Daillert V, Decottignies A, Mahon BF", "journal": "Drug Discovery Today", "year": "2009", "volumes": "14", "first page": "696", "last page": "705", "DOI": "10.1016/j.drudis.2009.03.007"}, {"title": "Antibody engineering for vaccine development", "authors": "Sahin U, Karikó K, Türeci Z", "journal": "Nature Reviews Drug Discovery", "year": "2014", "volumes": "13", "first page": "780", "last page": "792", "DOI": "10.1038/nrd4315"}, {"title": "Immune evasion strategies of pathogens and their countermeasures", "authors": "Mogensen TH, Paludan SR, Paludan CR", "journal": "Immunological Reviews", "year": "2011", "volumes": "242", "first page": "128", "last page": "146", "DOI": "10.1111/j.1600-065X.2011.01046.x"}, {"title": "Fc engineering of therapeutic antibodies: toward optimal efficacy and safety", "authors": "Lazar GA, Dang W, Cao Y, Xu L, Tsurushita N, et al.", "journal": "mAbs", "year": "2006", "volumes": "4", "first page": "1", "last page": "10", "DOI": "10.1080/19420860600835033"}, {"title": "Bispecific antibodies: a new class of immune-modulating therapeutic proteins", "authors": "Brinkmann U, Kontermann RE", "journal": "Journal of Immunotherapy", "year": "2017", "volumes": "40", "first page": "175", "last page": "189", "DOI": "10.1097/CJI.0000000000000234"}, {"title": "Antibody–drug conjugates: a new class of cancer therapeutics", "authors": "Teicher BA", "journal": "Clinical Cancer Research", "year": "2009", "volumes": "15", "first page": "1478", "last page": "1484", "DOI": "10.1158/1078-0432.CCR-08-2197"}, {"title": "Engineering antibodies for enhanced efficacy against infectious diseases", "authors": "Davis BH, Saphire EO, Crispin M, Wilson IA", "journal": "Nature Reviews Microbiology", "year": "2010", "volumes": "8", "first page": "738", "last page": "752", "DOI": "10.1038/nrmicro2324"}, {"title": "Fc engineering of therapeutic antibodies: strategies to optimize effector function", "authors": "Lazar GA, Zhang M, Xu L, Tsurushita N, Yang J, et al.", "journal": "mAbs", "year": "2006", "volumes": "4", "first page": "11", "last page": "17", "DOI": "10.1080/19420860600835034"}, {"title": "Bispecific antibodies for cancer immunotherapy", "authors": "Muller D, Kontermann RE", "journal": "Cancer Treatment Reviews", "year": "2010", "volumes": "36", "first page": "591", "last page": "602", "DOI": "10.1016/j.ctrv.2010.03.002"}, {"title": "Antibody–drug conjugates: past, present and future", "authors": "Teicher BA", "journal": "Journal of Medicinal Chemistry", "year": "2019", "volumes": "62", "first page": "2317", "last page": "2332", "DOI": "10.1021/acs.jmedchem.8b01546"}]}